GlaucomaApp: Interest in Electronic Applications for Patients With Glaucoma

• Sponsor: Wills Eye (Other)
• Overall Status: Completed
• CT.gov ID: NCT02659709
• Collaborator: (none)
• Enrollment: 50
• Location: 1
• Duration (Months): 16
• Patients Per Site Per Month: 3.1

Study Details

Study Description

Brief Summary

To evaluation interest in use of smartphone- and tablet-based application (app) for participants with glaucoma, ocular hypertension, those at risk and their caregivers.

Condition or Disease	Intervention/Treatment	Phase
Glaucoma	Device: Interest in medical education through social media

Detailed Description

This study is designed to determine the amount of interest in an educational application (app) on social media for glaucoma patients and their caregivers.

The purpose of this App is to enhance understanding of glaucoma by using short video tutorials. The App will include glaucoma eye drop medication reminders, a short video tutorial which aims to improve understanding of how visual field testing should be performed, how to administer eye drops and a feature that will enable participants to store and organize testing results using a mobile device.

Study Design

• Study Type: Observational
• Actual Enrollment: 50 participants
• Observational Model: Cohort
• Time Perspective: Prospective
• Official Title: Interest of Patients and Their Caregivers in A Smartphone- and Tablet-Based Application for Patients With Glaucoma
• Study Start Date: Jun 1, 2015
• Actual Primary Completion Date: Oct 1, 2016
• Actual Study Completion Date: Oct 1, 2016

Arms and Interventions

Arm	Intervention/Treatment
Glaucoma Patients and Caregivers Glaucoma patients and caregivers will complete a 20 item questionnaire providing demographic information, glaucoma eye drop compliance, interest in medication reminders, availability to smartphone, tablet and social media technology and interest in using a glaucoma application on social media.	Device: Interest in medical education through social media; Measuring interest in social media technology designed to educate glaucoma patients about disease, testing, and treatments with reminders for taking medications.; Other Names: Glaucoma App Interest

Outcome Measures

Primary Outcome Measures

1. Patients Owning Smartphone/Tablet Technology [1 hour]

   Responses collected from participants about owning access to social media via smartphone or tablet technology obtained by completing a 20 item questionnaire.

2. Patients Having Access to Social Media Via Smartphone or Tablet in the Home [1 hour]

   Responses collected from participants about their personal access, through other members in the home, to social media via smartphone or tablet technology obtained by completing a 20 item questionnaire.

Secondary Outcome Measures

1. Glaucoma Medication Compliance [1 hour]

   Responses collected from participants about compliance to using their glaucoma drops as prescribed obtained by completing a 20 item questionnaire.

2. Use of Medication Reminder [1 hour]

   Responses collected from participants about use of medication reminders for their glaucoma drops obtained by completing a 20 item questionnaire.

Eligibility Criteria

Criteria

• Ages Eligible for Study: 18 Years and Older
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: Yes

Inclusion Criteria:

• Anyone affected by glaucoma

• Family and friends of someone with glaucoma

Exclusion Criteria:

• unable to complete survey

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Wills Eye Hospital	Philadelphia	Pennsylvania	United States	19107

Sponsors and Collaborators

• Wills Eye

Investigators

• Principal Investigator: Jonathan S Myers, MD, Wills Eye Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

• Responsible Party: Jonathon Myers, Principal Investigator, Wills Eye
• ClinicalTrials.gov Identifier: NCT02659709
• Other Study ID Numbers: 14-413E
• First Posted: Jan 20, 2016
• Last Update Posted: Aug 5, 2019
• Last Verified: Jun 1, 2019

• Individual Participant Data (IPD) Sharing Statement: No
• Plan to Share IPD: No
• Studies a U.S. FDA-regulated Drug Product: No
• Studies a U.S. FDA-regulated Device Product: No
• Keywords provided by Jonathon Myers, Principal Investigator, Wills Eye: Glaucoma; Smartphone; Tablet; Application; Eye Drops
• Additional relevant MeSH terms: Glaucoma

Study Results

Participant Flow

Recruitment Details	Glaucoma patients and Caregivers were recruited from the Glaucoma Service at Wills Eye Hospital, Philadelphia, PA, USA.

Arm/Group Title	Glaucoma Patients and Caregivers
Arm/Group Description	Glaucoma patients and caregivers will test a glaucoma smartphone application (app) on smart phones or tablets then complete 20 item questionnaire providing demographic information, effectiveness and ease of use with the application designed to educate glaucoma patients about disease, testing, and treatments with reminders for taking medications.
Period Title: Overall Study
STARTED	50
COMPLETED	50
NOT COMPLETED	0

Baseline Characteristics

Arm/Group Title	Glaucoma Patients and Caregivers
Arm/Group Description	50 Glaucoma patients and/or caregivers will test a glaucoma application (app) on smart phones or tablets then complete a 20 item questionnaire providing demographic information, effectiveness and ease of use with the application designed to educate glaucoma patients about disease, testing, and treatments with reminders for taking medications.
Overall Participants	50
Age (Count of Participants)
<=18 years	1 2%
Between 18 and 65 years	32 64%
>=65 years	17 34%
Sex: Female, Male (Count of Participants)
Female	32 64%
Male	18 36%
Race (NIH/OMB) (Count of Participants)
American Indian or Alaska Native	0 0%
Asian	2 4%
Native Hawaiian or Other Pacific Islander	0 0%
Black or African American	9 18%
White	33 66%
More than one race	3 6%
Unknown or Not Reported	3 6%
Region of Enrollment (participants) [Number]
United States	50 100%

Outcome Measures

1. Primary Outcome

Title	Patients Owning Smartphone/Tablet Technology
Description	Responses collected from participants about owning access to social media via smartphone or tablet technology obtained by completing a 20 item questionnaire.
Time Frame	1 hour

Outcome Measure Data

Analysis Population Description

Participants responding Yes to owning a smartphone or tablet.

Arm/Group Title	Glaucoma Smartphone Application
Arm/Group Description	Glaucoma patients and/or caregivers answered a Questionnaire on availability to Smartphone or Tablet Usage and accessing social media. Questionnaire includes 20 items regarding demographic information, effectiveness of social media and compliance with glaucoma medications. From this information, Smartphone Application will be designed to educate glaucoma patients about the disease, testing, and treatments and also include reminders for taking medications.
Measure Participants	50
Count of Participants [Participants]	34 68%

2. Primary Outcome

Title	Patients Having Access to Social Media Via Smartphone or Tablet in the Home
Description	Responses collected from participants about their personal access, through other members in the home, to social media via smartphone or tablet technology obtained by completing a 20 item questionnaire.
Time Frame	1 hour

Outcome Measure Data

Analysis Population Description

Participants responding Yes to anyone in the house owning a smartphone or tablet.

Arm/Group Title	Glaucoma Smartphone Application
Arm/Group Description	Glaucoma patients and/or caregivers answered a Questionnaire on availability to Smartphone or Tablet Usage and accessing social media. Questionnaire includes 20 items regarding demographic information, effectiveness of social media and compliance with glaucoma medications. From this information, Smartphone Application will be designed to educate glaucoma patients about the disease, testing, and treatments and also include reminders for taking medications.
Measure Participants	50
Count of Participants [Participants]	39 78%

3. Secondary Outcome

Title	Glaucoma Medication Compliance
Description	Responses collected from participants about compliance to using their glaucoma drops as prescribed obtained by completing a 20 item questionnaire.
Time Frame	1 hour

Outcome Measure Data

Analysis Population Description

Participants responding Yes using their glaucoma eye drops as prescribed.

Arm/Group Title	Glaucoma Smartphone Application
Arm/Group Description	Glaucoma patients and/or caregivers answered a Questionnaire on availability to Smartphone or Tablet Usage and accessing social media. Questionnaire includes 20 items regarding demographic information, effectiveness of social media and compliance with glaucoma medications. From this information, Smartphone Application will be designed to educate glaucoma patients about the disease, testing, and treatments and also include reminders for taking medications.
Measure Participants	50
Count of Participants [Participants]	25 50%

4. Secondary Outcome

Title	Use of Medication Reminder
Description	Responses collected from participants about use of medication reminders for their glaucoma drops obtained by completing a 20 item questionnaire.
Time Frame	1 hour

Outcome Measure Data

Analysis Population Description

Participants responding Yes to using their glaucoma eye drops as prescribed without reminders.

Arm/Group Title	Glaucoma Smartphone Application
Arm/Group Description	Glaucoma patients and/or caregivers answered a Questionnaire on availability to Smartphone or Tablet Usage and accessing social media. Questionnaire includes 20 items regarding demographic information, effectiveness of social media and compliance with glaucoma medications. From this information, Smartphone Application will be designed to educate glaucoma patients about the disease, testing, and treatments and also include reminders for taking medications.
Measure Participants	50
Count of Participants [Participants]	28 56%

Adverse Events

Time Frame	1 hour
Arm/Group Title	Glaucoma Smartphone Application
Arm/Group Description	50 Glaucoma patients and caregivers will test a glaucoma smartphone application (app) on smart phones or tablets then complete 20 item questionnaire providing demographic information, effectiveness and ease of use with the application. Smartphone Application: Smartphone Application designed to educate glaucoma patients about disease, testing, and treatments with reminders for taking medications.
All Cause Mortality
	Glaucoma Smartphone Application
	Affected / at Risk (%)	# Events
Total	0/50 (0%)
Serious Adverse Events
	Glaucoma Smartphone Application
	Affected / at Risk (%)	# Events
Total	0/50 (0%)
Other (Not Including Serious) Adverse Events
	Glaucoma Smartphone Application
	Affected / at Risk (%)	# Events
Total	0/50 (0%)

Limitations/Caveats

Participants were recruited from single urban eye care hospital. Results did not distinguish between glaucoma patients and caregivers. Participation did not include testing of the application.

More Information

Certain Agreements

Principal Investigators are NOT employed by the organization sponsoring the study.

There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.